Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

University of Michigan

1500 East Medical Center Dr     
Ann Arbor , MI 48109
USA

 

Principal Investigator:
Scott Schuetze, MD
Contact:
Gino Metko 734-647-2095 minom@umich.edu Rivka Siden 734-936-8210 sidenr@umich.edu
Activation Status of this Site:
Closed
Notes about this Site:
University of Michigan Website:
https://www.umms.med.umich.edu/engage/disp_pub_main.do

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.